Weight Loss Medications in Canada: Complete Guide to GLP-1 Programs

Weight Loss Medications in Canada

Canada has a well-regulated framework for weight loss medications. Health Canada approves GLP-1 receptor agonists for medically supervised obesity management, and several telehealth platforms now make access faster and more convenient than ever before.

Unlike the United States, compounded versions of GLP-1 injections (such as compounded semaglutide or tirzepatide) are not permitted in Canada. Health Canada requires that all weight loss injection medications be Health Canada-approved brand-name products. This is an important distinction for anyone comparing Canadian and American programs.

Health Canada-Approved Weight Loss Medications

The following brand-name GLP-1 medications are approved by Health Canada for weight management:

• Ozempic (semaglutide) — Originally approved for type 2 diabetes, widely used for weight loss
• Wegovy (semaglutide) — Specifically approved for chronic weight management in adults
• Saxenda (liraglutide) — Daily injection approved for long-term weight management

Why No Compounded Injections in Canada?

In Canada, Health Canada regulations under the Food and Drugs Act restrict the compounding of medications that are commercially available in approved form. Since semaglutide and tirzepatide are available as brand-name products (Ozempic, Wegovy, Mounjaro), compounding pharmacies are not permitted to produce or sell compounded versions of these substances for weight loss purposes. This differs from US FDA enforcement discretion policies that temporarily allowed compounded GLP-1s during shortage periods.

The result is that Canadian patients using telehealth weight loss platforms will receive authentic, brand-name GLP-1 medications — which come with consistent quality, dosing, and clinical support.

How Online Weight Loss Programs Work in Canada

Canadian telehealth weight loss clinics follow a straightforward process:

1. Complete an online intake form — provide your health history, weight, goals, and relevant conditions
2. Physician review — a licensed Canadian physician reviews your information and determines eligibility
3. Prescription issued — if approved, a prescription for a Health Canada-approved GLP-1 medication is issued
4. Pharmacy fulfillment — your medication is dispensed by a licensed Canadian pharmacy and shipped to your door
5. Ongoing monitoring — regular follow-ups to adjust dosing and track progress

Who Qualifies for Weight Loss Medications in Canada?

General eligibility for GLP-1 weight loss medications in Canada typically requires:

• BMI of 30 or higher, or
• BMI of 27 or higher with at least one weight-related health condition (e.g., type 2 diabetes, hypertension, sleep apnea)
• Adults 18 years of age or older
• No contraindications to GLP-1 receptor agonists

Each provider conducts their own clinical screening. A licensed physician makes the final determination based on your individual health profile.

What Does Weight Loss Medication Cost in Canada?

The cost of GLP-1 weight loss programs in Canada varies by provider and medication. Brand-name medications can range from approximately $99 to $300+ per month. Some provincial drug benefit programs may provide partial coverage for medications like Ozempic when prescribed for eligible conditions. Private insurance plans vary widely — check your plan details.

Canadian telehealth providers like Direct Meds and Felix Health offer transparent pricing with the consultation, prescription, and often shipping included in their monthly fee.